Rating History
Dissemination Date Long-Term Rating Short-Term Rating Outlook Action Rating Watch
21-Mar-25 BBB A2 Stable Upgrade -
21-Mar-24 BBB- A2 Stable Maintain -
21-Mar-23 BBB- A2 Stable Maintain -
31-Mar-22 BBB- A3 Stable Maintain -
26-Aug-21 BBB- A3 Stable Maintain -
About the Entity

Welcon Chemicals ("Welcon" or "the Company") was incorporated in 1994. The Company stands as a pioneering entity within the Allahdin Group and offers a variety of agri-based productions ranging from urea and DAP-based fertilizers to pesticides and seed varieties. The Company’s plant is located at Industrial Estate Multan.
Welcon is majorly owned by Mr. Zain Iftikhar (~68%), followed by Ch. Zia ur Rehman (~15%), Ch. Iftikhar Nazir (~13%), Mr. Masood ur Rehman (~2%), and Ms. Ghazala Ghazni (~2%) (w/o Ch. Iftikhar Nazir – the Group's Chairman). A team of professionals assists the BoD's Chairman and the CEO of the Company.

Rating Rationale

The assigned ratings of Welcon Chemicals (Pvt) Limited (“Welcon” or “the Company”) continue to derive strength from the long‐standing experience of the Sponsors, established track record for operations, and a strong competitive position. The Company operates as a dynamic player in the pesticide industry, specializing in a comprehensive range of Agrochemical products. The Company has a diversified revenue stream generating ~68% of revenue from pesticides, followed by seeds (~17%) and fertilizers (~15%). The Company operates through a robust dealer network, with over 1,000 dealers strategically located nationwide. Welcon has expanded its product portfolio by incorporating locally produced biofertilizers, a cost-effective and efficient substitute for urea and DAP-based fertilizers. While the raw materials for pesticides are procured predominantly from China, raw material for fertilizers is procured locally from the associated companies. To effectively mitigate risks, the Company employs a streamlined procurement approach and reinforces its business presence in the Punjab region. During FY24, the Company witnessed a value-driven increase of ~7.7% in topline, primarily from pesticides. However, overall business margins have been squeezed due to increased costs. On the financial risk front, the Company relies significantly on short-term borrowings to manage its working capital requirements. Welcon holds a stable capital structure along with adequate coverages.

Key Rating Drivers

The ratings are dependent upon an improvement in the business and financial profile of the Company. Any deterioration in the topline, margins, or cashflows remains critical to the ratings. The Company’s sustained business performance remains vital to the ratings.

Profile
Legal Structure

Welcon Chemicals (Pvt) Ltd ('Welcon' or 'the Company') is a private limited Company incorporated in 1994 under the Companies Act,2017.


Background

Allahdin Group of Companies ('the Group') is among the leading players in the pesticide sector. During the 1980s, the sponsoring family was primarily engaged in the construction business. One of the four brothers was associated with the agriculture industry and had the relevant knowledge base required to enter the industry. The Company was subsequently established and paved the family’s path into the agriculture industry of Pakistan.


Operations

The Company's activities involve imports, formulations, manufacturing & marketing of all kinds of pesticides (Insecticides, Herbicides, Fungicides, Insect Growth Regulators), fertilizers and micronutrients (liquid & granules), plant growth regulators, seeds of different field crops & vegetables, etc. The Company's head office is located in Lahore. The formulation facility is at Industrial Estate Multan, which is equipped with Chinese machinery and technology. The Company operates through more than 1,000 dealers all across Pakistan.


Ownership
Ownership Structure

The Company's ownership transitioned to the new generation. Mr. Zain Iftikhar Ch. possesses a majority shareholding of ~68%, followed by Ch. Zia ur Rehman with 15%, Ch. Iftikhar Nazir with 13%, Mr. Masood ur Rehman with 2%, and Ms. Ghazala Ghazni with a 2% stake.


Stability

Although there is no formal succession plan, the ownership of the Company rests among the family members.


Business Acumen

The Company has a strong history of succeeding in agriculture. They have created synergies throughout Pakistan by using cutting-edge technology and providing one-of-a-kind services. The Group is equipped with people with vision, wisdom, and unique skills.


Financial Strength

The Group's history dates back to the 1990s, and vested business interests in Agriculture, Bottling, and the Pharmaceutical industry. The Group will support the Company if need be.


Governance
Board Structure

The control of the Company is vested with a two-member Board comprising the CEO and a Director. Both members are actively involved in the operations of the Company. However, the final decision is approved by the Chairman of the Group.


Members’ Profile

All members have been with the organization for a long. Mr. Zain possesses significant knowledge, skillset, and over a decade of experience in the pesticide sector. He is the Chairman & Chief Executive Officer (CEO) of the Company.


Board Effectiveness

The Board meets frequently, and minutes are documented as per the requirement. However, no Board committees exist to assist the Company's Board. 


Financial Transparency

The External Auditors of the Company, M/S. HLB Ijaz Tabussum & Co., Chartered Accountants, a "B" category QCR-rated firm, expressed an unqualified opinion on financial statements for the period ended FY24.


Management
Organizational Structure

Business operations are divided into four key functions, namely: (i) Sales & Marketing, (ii) Finance, (iii) HR & IT, and (iv) Taxation & Accounts. The reporting lines converge to the CEO, who is the man at the last mile, i.e., the key decision maker.


Management Team

Mr. Zain Iftikhar Ch. is the key shareholder and CEO of the Company and possesses the required knowledge, expertise, and skillset. He has been with the business for a long time and is assisted by a team of professionals.


Effectiveness

Management meetings are conducted as and when required, and senior management contributes their insights to the decision-making process. Ch. Iftikhar Nazir serves as the ultimate authority in all decision-making matters. The Company does not have any formalized management committees in place.


MIS

The Company has built an in-house ERP system. It has all the required modules like inventory, sales & marketing, finance, procurement, HR, etc. It generates reports on a daily, weekly, and monthly basis.


Control Environment

The frequent meetings at the management level demonstrate that the Company's monitoring and evaluating systems are appropriate. The monthly and quarterly MIS reports of the Company include detailed segment and product performance data that is evaluated monthly by senior management.


Business Risk
Industry Dynamics

The agricultural sector plays a pivotal role in Pakistan's economy, contributing ~25% to the GDP and serving as a crucial source of raw materials for various industries. The industry heavily relies on pesticides to enhance crop protection and cultivation practices (Agro Chemicals). The pesticide sector is significantly dependent on imports as ~85-90% of raw material is imported from China. In FY23, the pesticide industry's estimated value stood at ~PKR 103.7bln, marking a YoY increase of ~5.4%. This growth is attributed to the overall expansion of the crops sector and the subsequent rise in demand. Additionally, increased prices have further contributed to this upward trend. In FY23, pesticide imports reached around ~PKR 36bln, reflecting a ~19% YoY increase. Among these imports, insecticides accounted for the majority. The sector's overall leveraging remains moderate, with stable coverage ratios. Going forward, the sector's overall outlook is expected to remain stable.


Relative Position

The Group holds a strong market position and brand image in the industry.


Revenues

The Company has maintained a healthy business risk profile backed by its established industry presence and robust sales network nationwide. The Company has diversified revenue streams from pesticides, generating ~68% of the revenue, followed by seeds (~17%) and fertilizer (~15%). During FY24, the revenue of the Company clocked at ~PKR 2,347mln (FY23: ~PKR 2,180mln), witnessing a slight increase of ~8%. During 6MFY25, the Company reported revenue of ~PKR 1,040mln. Improvement in revenue was majorly attributed to price changes in products. Going forward, revenues are expected to increase, given the Company's plan to sell its products in the wholesale market. 


Margins

In FY24, the Company's gross profits stood at ~PKR 426mln, marking a ~6.2% increase from FY23's ~PKR 401mln. The gross profit margin decreased to 18.1% in FY24 (FY23: ~18.4%), attributed to higher raw material prices. Operating profits surged to ~PKR 163mln in FY24 (FY23:~PKR 144mln), with the operating profit margin slightly increasing to ~6.9% (FY23: ~6.6%), indicating efficient administrative and selling expense management by the Company. An increase in taxes and finance costs during FY24 resulted in a net profit of ~PKR 29mln (FY23: ~PKR 131mln). Therefore, the Company's net margin dropped significantly to ~1.2% (FY23: ~6%). During 6MFY25, the Company reported a gross profit of ~PKR ~207mln and a net profit of ~PKR 29mln, with gross margin clocking at ~19.9% and a net margin of ~2.4%, respectively. Going forward, profits are expected to follow a similar trajectory. 


Sustainability

Going forward, the management will focus on sustaining its cost leadership and performance uptrend. The Company is securing its business by registering its farmers and providing them pesticides and in return purchasing their crops. The idea was implemented in the cotton and wheat segments. Moreover, the Company plans to sell its products in the wholesale market. 


Financial Risk
Working capital

As of FY24, inventory turnover days increased slightly to ~126 days (FY23: ~124 days) due to a decrease in demand, whereas trade receivable days increased significantly to ~65 days (FY23: ~44 days), demonstrating the Company's inefficiency in collecting receivables. Trade payable days improved slightly to ~15 days (FY23: ~13 days), highlighting the Company's ability to extend trade credit. Thus, the net working capital cycle witnessed a deterioration reported at ~176 days (FY23: ~155 days). As of 6MFY25, inventory days were reported at ~132 days, followed by trade receiveable days of ~83 days and trade payable days of ~8 days. Resultantly, net working capital days stood at ~207 days. The Company's borrowing cushion remains moderate. 


Coverages

As of FY24, the FCFO of the Company stood at ~PKR 182mln (FY23: ~PKR 152mln) due to increased EBITDA. However, finance costs increased to ~PKR 82mln (FY23: ~PKR 79mln). Consequently, the Company's interest coverage ratio (FCFO / Finance Cost) improved to ~2.2x as of FY24 (FY23: ~1.9x). As of 6MFY25, the Company reported FCFO of ~PKR 97mln, whereas finance cost was reported at ~PKR 40mln, resulting in interest cover of ~2.5x. The Company consistently exhibits the capability to cover its interest expenses sufficiently. Looking forward, the Company anticipates that improved market dynamics will positively impact its Free Cash Flow from Operations (FCFO). Moreover, an incremental decrease in policy rates would further decrease finance costs.


Capitalization

The Company maintains a moderately leveraged capital structure with a ratio of ~32% as of FY24 (FY23: ~29%). The ratio has increased slightly due to an increase in total borrowings reported at ~PKR 718mln (FY23: ~PKR 607mln). Whereas the equity grows and stands at PKR~1,504mln (FY23: PKR 1,475mln) due to profit accumulation. As of 6MFY25, the leverage ratio was reported at ~20%, with total borrowings standing at ~PKR 382mln and equity of ~PKR 1,529mln.


 
 

Mar-25

www.pacra.com


Dec-24
6M
Jun-24
12M
Jun-23
12M
Jun-22
12M
A. BALANCE SHEET
1. Non-Current Assets 1,161 1,157 1,164 434
2. Investments 0 0 0 0
3. Related Party Exposure 196 249 79 28
4. Current Assets 1,280 1,628 1,194 1,163
a. Inventories 544 964 651 831
b. Trade Receivables 468 478 360 163
5. Total Assets 2,636 3,035 2,438 1,625
6. Current Liabilities 699 797 350 565
a. Trade Payables 49 44 149 10
7. Borrowings 382 718 607 515
8. Related Party Exposure 0 0 0 38
9. Non-Current Liabilities 26 15 6 5
10. Net Assets 1,529 1,504 1,475 501
11. Shareholders' Equity 1,529 1,504 1,475 501
B. INCOME STATEMENT
1. Sales 1,040 2,347 2,180 2,034
a. Cost of Good Sold (833) (1,922) (1,778) (1,669)
2. Gross Profit 207 426 401 366
a. Operating Expenses (124) (263) (258) (233)
3. Operating Profit 82 163 144 133
a. Non Operating Income or (Expense) (3) 2 82 (3)
4. Profit or (Loss) before Interest and Tax 80 165 226 129
a. Total Finance Cost (42) (85) (79) (59)
b. Taxation (13) (51) (16) (30)
6. Net Income Or (Loss) 25 29 131 40
C. CASH FLOW STATEMENT
a. Free Cash Flows from Operations (FCFO) 97 182 152 149
b. Net Cash from Operating Activities before Working Capital Changes 63 115 87 90
c. Changes in Working Capital 48 (44) (140) (41)
1. Net Cash provided by Operating Activities 111 71 (53) 49
2. Net Cash (Used in) or Available From Investing Activities 0 19 145 14
3. Net Cash (Used in) or Available From Financing Activities (24) (86) (14) (49)
4. Net Cash generated or (Used) during the period 87 5 77 14
D. RATIO ANALYSIS
1. Performance
a. Sales Growth (for the period) -11.4% 7.7% 7.1% 14.5%
b. Gross Profit Margin 19.9% 18.1% 18.4% 18.0%
c. Net Profit Margin 2.4% 1.2% 6.0% 2.0%
d. Cash Conversion Efficiency (FCFO adjusted for Working Capital/Sales) 14.0% 5.9% 0.6% 5.3%
e. Return on Equity [ Net Profit Margin * Asset Turnover * (Total Assets/Shareholders' Equity )] 3.3% 2.0% 13.2% 8.6%
2. Working Capital Management
a. Gross Working Capital (Average Days) 215 191 168 209
b. Net Working Capital (Average Days) 207 176 155 207
c. Current Ratio (Current Assets / Current Liabilities) 1.8 2.0 3.4 2.1
3. Coverages
a. EBITDA / Finance Cost 2.5 2.5 2.2 2.9
b. FCFO / Finance Cost+CMLTB+Excess STB 1.8 1.5 1.2 1.4
c. Debt Payback (Total Borrowings+Excess STB) / (FCFO-Finance Cost) 0.7 0.7 1.0 1.2
4. Capital Structure
a. Total Borrowings / (Total Borrowings+Shareholders' Equity) 20.0% 32.3% 29.2% 50.7%
b. Interest or Markup Payable (Days) 0.0 0.0 0.0 0.0
c. Entity Average Borrowing Rate 14.7% 13.4% 17.5% 11.5%

Mar-25

www.pacra.com

Mar-25

www.pacra.com

  1. Rating Team Statements
    1. Rating is just an opinion about the creditworthiness of the entity and does not constitute a recommendation to buy, hold, or sell any security of the entity rated or to buy, hold, or sell the security rated, as the case may be. (Chapter III; 14-3-(x))
    2. Conflict of Interest
      1. The Rating Team or any of their family members have no interest in this rating (Chapter III; 12-2-(j))
      2. PACRA, the analysts involved in the rating process, and members of its rating committee and their family members do not have any conflict of interest relating to the rating done by them (Chapter III; 12-2-(e) & (k))
      3. The analyst is not a substantial shareholder of the customer being rated by PACRA [Annexure F; d-(ii)]
      4. Explanation: for the purpose of the above clause, the term "family members" shall include only those family members who are dependent on the analyst and members of the rating committee.
  2. Restrictions
    1. No director, officer, or employee of PACRA communicates the information acquired by him for use for rating purposes to any other person, except where required under law to do so. (Chapter III; 10-(5))
    2. PACRA does not disclose or discuss with outside parties or make improper use of the non-public information which has come to its knowledge during a business relationship with the customer. (Chapter III; 10-7-(d))
    3. PACRA does not make proposals or recommendations regarding the activities of rated entities that could impact a credit rating of the entity subject to rating. (Chapter III; 10-7-(k))
  3. Conduct of Business
    1. PACRA fulfills its obligations in a fair, efficient, transparent, and ethical manner and renders high standards of services in performing its functions and obligations. (Chapter III; 11-A-(a))
    2. PACRA uses due care in the preparation of this Rating Report. Our information has been obtained from sources we consider to be reliable, but its accuracy or completeness is not guaranteed. PACRA does not, in every instance, independently verify or validate information received in the rating process or in preparing this Rating Report. (Clause 11-(A)(p))
    3. PACRA prohibits its employees and analysts from soliciting money, gifts, or favors from anyone with whom PACRA conducts business. (Chapter III; 11-A-(q))
    4. PACRA ensures before the commencement of the rating process that an analyst or employee has not had a recent employment or other significant business or personal relationship with the rated entity that may cause or may be perceived as causing a conflict of interest. (Chapter III; 11-A-(r))
    5. PACRA maintains the principle of integrity in seeking rating business. (Chapter III; 11-A-(u))
    6. PACRA promptly investigates in the event of misconduct or a breach of the policies, procedures, and controls, and takes appropriate steps to rectify any weaknesses to prevent any recurrence, along with suitable punitive action against the responsible employee(s). (Chapter III; 11-B-(m))
  4. Independence & Conflict of Interest
    1. PACRA receives compensation from the entity being rated or any third party for the rating services it offers. The receipt of this compensation has no influence on PACRA’s opinions or other analytical processes. In all instances, PACRA is committed to preserving the objectivity, integrity, and independence of its ratings. Our relationship is governed by two distinct mandates: i) rating mandate - signed with the entity being rated or issuer of the debt instrument, and ii) fee mandate - signed with the payer, which can be different from the entity.
    2. PACRA does not provide consultancy/advisory services or other services to any of its customers or their associated companies and associated undertakings that are being rated or have been rated by it during the preceding three years, unless it has an adequate mechanism in place ensuring that the provision of such services does not lead to a conflict of interest situation with its rating activities. (Chapter III; 12-2-(d))
    3. PACRA discloses that no shareholder directly or indirectly holding 10% or more of the share capital of PACRA also holds directly or indirectly 10% or more of the share capital of the entity which is subject to rating or the entity which issued the instrument subject to rating by PACRA. (Chapter III; 12-2-(f))
    4. PACRA ensures that the rating assigned to an entity or instrument is not affected by the existence of a business relationship between PACRA and the entity or any other party, or the non-existence of such a relationship. (Chapter III; 12-2-(i))
    5. PACRA ensures that the analysts or any of their family members shall not buy, sell, or engage in any transaction in any security which falls in the analyst’s area of primary analytical responsibility. This clause, however, does not apply to investments in securities through collective investment schemes. (Chapter III; 12-2-(l))
    6. PACRA has established policies and procedures governing investments and trading in securities by its employees and for monitoring the same to prevent insider trading, market manipulation, or any other market abuse. (Chapter III; 11-B-(g))
  5. Monitoring and Review
    1. PACRA monitors all the outstanding ratings continuously, and any potential change therein due to any event associated with the issuer, the security arrangement, the industry, etc., is disseminated to the market immediately and in an effective manner after appropriate consultation with the entity/issuer. (Chapter III; 17-(a))
    2. PACRA reviews all the outstanding ratings periodically on an annual basis. Provided that public dissemination of annual review and in an instance of change in rating will be made. (Chapter III; 17-(b))
    3. PACRA initiates an immediate review of the outstanding rating upon becoming aware of any information that may reasonably be expected to result in downgrading of the rating. (Chapter III; 17-(c))
    4. PACRA engages with the issuer and the debt securities trustee to remain updated on all information pertaining to the rating of the entity/instrument. (Chapter III; 17-(d))
  6. Probability of Default
    1. PACRA’s Rating Scale reflects the expectation of credit risk. The highest rating has the lowest relative likelihood of default (i.e., probability). PACRA’s transition studies capture the historical performance behavior of a specific rating notch. Transition behavior of the assigned rating can be obtained from PACRA’s Transition Study available at our website. (www.pacra.com) However, the actual transition of rating may not follow the pattern observed in the past. (Chapter III; 14-3(f)(vii))
  7. Proprietary Information
    1. All information contained herein is considered proprietary by PACRA. Hence, none of the information in this document can be copied or otherwise reproduced, stored, or disseminated in whole or in part in any form or by any means whatsoever by any person without PACRA’s prior written consent.

Mar-25

www.pacra.com